NASH

Events
Card image cap
Partner Content

6th Obesity & NASH Drug Development Summit 2022

While investment in NASH has waned in the context of rigid histological endpoints and clinical setbacks, opportunities to target obesity and other metabolic disorders through the lens of a holistic